NCT07043608
Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, Variants, or PubMed publications.

Have questions, comments, or suggestions? - Let us know!

Email us at : ckbsupport@genomenon.com

NCT ID NCT07043608
Title Zanzalintinib for Metastatic Clear Cell Renal Cell Carcinoma With Bone Metastases (ZAMBONI)
Acronym ZAMBONI
Recruitment Not yet recruiting
Gender both
Phase Phase II
Variant Requirements No
Sponsors Kelly Fitzgerald, MD
Indications
Therapies
Age Groups: adult | senior
Covered Countries USA


No variant requirements are available.